Published in J Natl Cancer Inst on October 01, 1972
Cross reactivity of an alloantigen present on normal cells with the tumour-specific transplantation-type antigen of the acute myeloid leukaemia (SAL) of rats. Br J Cancer (1976) 0.79
Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells. Immunology (1985) 0.79
Analysis of heteroantisera to cells from human malignant effusions by immunofluorescence and protein A binding. Br J Cancer (1977) 0.75
Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells. Immunology (1975) 0.75
Modulation of the murine immune response to human IgG by complexing with monoclonal antibodies. I. Antibody responses to determinants on the constant region of light chains and gamma chains. Immunology (1987) 0.75
Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest (1986) 2.82
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58
Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG) Ann Intern Med (1994) 1.81
Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med (1987) 1.68
Increase in circulating stem cells following chemotherapy in man. Blood (1976) 1.58
Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med (1971) 1.49
The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest (1973) 1.42
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
Ultrastructural localization of the third and fourth components of complement on complement-cell complexes. Am J Pathol (1968) 1.39
Transthoracic and transvenous pacemakers. A comparative clinical experience with 131 implantable units. Br Heart J (1970) 1.33
Nephrotoxic serum nephritis in complement intact and deficient mice. J Immunol (1967) 1.33
Workshop on bioanalytical methods validation for macromolecules: summary report. Pharm Res (2001) 1.32
Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen. J Natl Cancer Inst (1973) 1.23
Immunology and morphology of acute post-streptococcal glomerulonephritis. Lab Invest (1966) 1.22
Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease. Am J Med (1977) 1.22
Subclinical immune complexes in the glomeruli of kidneys postmortem. Am J Med (1974) 1.21
The in vitro transformation of frozen-stored lymphocytes in the mixed lymphocyte reaction and in culture with phytohemagglutinin and specific antigens. J Exp Med (1970) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch Neurol (1983) 1.12
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet (1984) 1.06
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. J Clin Oncol (1992) 1.06
Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res (1985) 1.04
Reactivity of human lymphocytes to autologous and homologous serum. J Immunol (1969) 1.04
Familial cardiac myxoma: emphasis on unusual clinical manifestations. J Thorac Cardiovasc Surg (1979) 1.03
The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study. Lab Invest (1966) 1.03
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer (1980) 1.00
Spontaneous tension pneumopericardium. N Engl J Med (1968) 1.00
The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen. J Immunol Methods (1976) 0.99
Application of the Beckman JE6-B Elutriator System in the isolation of human monocyte subpopulations. Scand J Haematol (1985) 0.99
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant (1995) 0.99
The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation. Cell Immunol (1973) 0.98
Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol (1984) 0.98
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer (1983) 0.97
Studies of the proteins of lacrimal secretions. J Immunol (1968) 0.97
The characteristics of lymphocyte tritiated thymidine incorporation in response to mumps virus. Cell Immunol (1972) 0.96
Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC). J Immunol (1983) 0.96
Isolation of leukemic blasts from peripheral blood by density gradient centrifugation. J Lab Clin Med (1970) 0.95
Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium. Blood (1987) 0.94
Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen. Cell Immunol (1975) 0.94
Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants. Rev Eur Etud Clin Biol (1973) 0.92
Primary structure of human deoxycytidylate deaminase and overexpression of its functional protein in Escherichia coli. J Biol Chem (1993) 0.92
Preservation of cellular antigenicity of tumor cells by the use of formalin fixation. Cancer Res (1972) 0.92
Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients. J Antimicrob Chemother (1983) 0.91
The effect of synthetic polynucleotides on immunologically induced tritiated thymidine incorporation. Amplification of response. Transplantation (1972) 0.90
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol (2000) 0.90
Methods in laboratory investigation. Isolation of guinea pig monocytes and Kurloff cells: characterization of monocyte subsets by morphology, cytochemistry, and adherence. Lab Invest (1984) 0.89
Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol (1993) 0.89
Pure red cell aplasia associated with angioimmunoblastic lymphadenopathy with dysproteinemia. Am J Hematol (1994) 0.89
Purification of human monocytes: isolation and collection of large numbers of peripheral blood monocytes. J Immunol Methods (1980) 0.89
Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood (1977) 0.89
Subclinical immune complex nephritis in patients with Hodgkin's disease. Cancer Res (1974) 0.89
Abnormal profile of human nucleolytic activity as a test for cancer. J Natl Cancer Inst (1975) 0.88
Community mental health centers and the "seed money" concept: effects of terminating federal funds. Community Ment Health J (1979) 0.87
Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma. Cancer Res (1976) 0.87
Conduction tissue anomalies in absence of the right superior caval vein. Int J Cardiol (1985) 0.86
Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol (1975) 0.86
The processing of human bone marrow for cryopreservation and reinfusion. Biomedicine (1976) 0.86
Cryopreservation of lymphocytes for use in in vitro assays of cellular immunity. J Immunol Methods (1976) 0.86
Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice. J Pharm Sci (1995) 0.85
Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro. Cancer Treat Rep (1976) 0.84
Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp Hematol (1986) 0.84
A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol (1980) 0.84
Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses. J Pharm Sci (1996) 0.83
Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. Eur J Cancer (1977) 0.83
In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3. J Immunol Methods (1974) 0.83
Isolation and expression of rat thymidylate synthase cDNA: phylogenetic comparison with human and mouse thymidylate synthases. Biochim Biophys Acta (1995) 0.83
A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol (1980) 0.83
Experience with a mixed lymphocyte-tumor reaction as a method of detecting antigenic differences between normal and neoplastic cells. J Immunol (1970) 0.83
Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion (1974) 0.82
Identification and screening of women at high risk of breast cancer. Cancer Detect Prev (1988) 0.82
Rigors with vancomycin. Ann Intern Med (1991) 0.82
A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol (1982) 0.82
The immunosuppressive effect of amantadine upon the response of lymphocytes to specific antigens in vitro. Transplantation (1971) 0.82
Osteosarcoma arising in osteogenesis imperfecta. Pediatr Radiol (1979) 0.82
Purification of human lymphocytes by simple centrifugation. Rev Eur Etud Clin Biol (1970) 0.82
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation. Cancer (1982) 0.82
Alteration of human serum ribonuclease activity in malignancy. CRC Crit Rev Clin Lab Sci (1978) 0.82
The role of the human granulocyte as an antigen in the mixed lymphocyte reaction: the lack of stimulation. Transplantation (1972) 0.81
Restoration of the reactivity of frozen stored human lymphocytes in the mixed lymphocyte reaction and in response to specific antigens. Transplantation (1972) 0.81
Transformation of mouse lymphocytes to allogeneic lymphocytes and phytohemagglutinin. J Immunol (1970) 0.81
Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice. J Natl Cancer Inst (1973) 0.81
Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay. Transplantation (1972) 0.80
Complexing Rauscher leukemia virus reverse transcriptase with human plasma ribonuclease from Hodgkin's disease patients. J Biol Chem (1977) 0.80
Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation. Rev Infect Dis (1990) 0.80
Parameters for effective use of synthetic double stranded polynucleotides in the amplification of immunologically induced lymphocyte tritiated thymidine incorporation. Cell Immunol (1974) 0.80
Functional integrity of cryopreserved human monocytes. J Natl Cancer Inst (1981) 0.80
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. Leukemia (1996) 0.80
Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J Lab Clin Med (1989) 0.80
Electrophoretic distributions of human peripheral blood mononuclear white cells from normal subjects and from patients with acute lymphocytic leukemia. Proc Natl Acad Sci U S A (1976) 0.79
Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. Bone Marrow Transplant (1994) 0.79
Temporal relationships between the major complications of bone marrow transplantation for leukemia. Bone Marrow Transplant (1989) 0.79
Antibody response in patients with acute nonlymphocytic leukemia. Cancer (1976) 0.79
Passive administration of antiserum and complement in producing anti-EL4 cytotoxic activity in the serum of C57BL-6 mice. J Natl Cancer Inst (1973) 0.79
The effects of tissue processing on markers for T and B cells from solid tissues. Am J Clin Pathol (1977) 0.79
Fractionation of spleen and serum in attempts to isolate the radiation-leukemia protection factor. Cancer Res (1969) 0.79
Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles. Cell Immunol (1975) 0.79
Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: a preliminary report. Transplant Proc (1987) 0.79
Quality of life in adult recipients of bone marrow transplantation. Psychol Rep (1994) 0.78
Mood, coping style, and personality functioning among adult bone marrow transplant candidates. Psychosomatics (1993) 0.78